GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $5,336,000 | -1.1% | 122,574 | -1.0% | 0.07% | +12.9% |
Q1 2022 | $5,396,000 | -8.7% | 123,874 | -7.5% | 0.06% | -3.1% |
Q4 2021 | $5,908,000 | +17.1% | 133,974 | +1.5% | 0.06% | +6.7% |
Q3 2021 | $5,045,000 | -54.0% | 132,042 | -7.7% | 0.06% | -6.2% |
Q2 2021 | $10,960,000 | -2.1% | 143,108 | -54.4% | 0.06% | -55.2% |
Q1 2021 | $11,199,000 | -5.2% | 313,772 | -2.2% | 0.14% | -14.4% |
Q4 2020 | $11,810,000 | -3.4% | 320,923 | -1.2% | 0.17% | -14.4% |
Q3 2020 | $12,223,000 | -18.0% | 324,742 | -11.1% | 0.20% | -23.8% |
Q2 2020 | $14,903,000 | +11.7% | 365,358 | +3.7% | 0.26% | -5.5% |
Q1 2020 | $13,343,000 | -19.6% | 352,160 | -0.3% | 0.27% | +0.7% |
Q4 2019 | $16,603,000 | +2.5% | 353,338 | -6.9% | 0.27% | -5.3% |
Q3 2019 | $16,193,000 | +4.7% | 379,403 | -1.8% | 0.28% | +2.2% |
Q2 2019 | $15,469,000 | -4.6% | 386,542 | -0.4% | 0.28% | -7.6% |
Q1 2019 | $16,212,000 | +13.7% | 387,938 | +4.0% | 0.30% | -1.0% |
Q4 2018 | $14,259,000 | -10.2% | 373,162 | -5.6% | 0.30% | +3.8% |
Q3 2018 | $15,885,000 | -57.1% | 395,454 | -56.9% | 0.29% | -59.9% |
Q2 2018 | $36,994,000 | +5.0% | 917,735 | +1.8% | 0.73% | +3.7% |
Q1 2018 | $35,238,000 | +14.5% | 901,929 | +4.0% | 0.70% | +16.7% |
Q4 2017 | $30,771,000 | +1.8% | 867,536 | +16.5% | 0.60% | -4.3% |
Q3 2017 | $30,230,000 | -5.1% | 744,591 | +0.8% | 0.63% | -9.2% |
Q2 2017 | $31,857,000 | +3.8% | 738,790 | +1.4% | 0.70% | -0.9% |
Q1 2017 | $30,704,000 | +18.1% | 728,262 | +7.9% | 0.70% | +11.3% |
Q4 2016 | $26,002,000 | -13.8% | 675,189 | -3.5% | 0.63% | -16.2% |
Q3 2016 | $30,172,000 | -0.6% | 699,557 | -0.1% | 0.75% | -1.3% |
Q2 2016 | $30,340,000 | +2.5% | 700,041 | -4.1% | 0.76% | -1.0% |
Q1 2016 | $29,595,000 | +3.5% | 729,833 | +3.0% | 0.77% | 0.0% |
Q4 2015 | $28,597,000 | +5.5% | 708,732 | +0.6% | 0.77% | -2.2% |
Q3 2015 | $27,097,000 | -3.5% | 704,737 | +4.5% | 0.79% | +2.1% |
Q2 2015 | $28,079,000 | -8.9% | 674,156 | +0.9% | 0.77% | -9.6% |
Q1 2015 | $30,824,000 | +12.9% | 667,898 | +4.6% | 0.85% | +11.5% |
Q4 2014 | $27,297,000 | -9.3% | 638,667 | -2.4% | 0.76% | -14.9% |
Q3 2014 | $30,096,000 | -12.4% | 654,694 | +1.9% | 0.90% | -10.8% |
Q2 2014 | $34,353,000 | +0.9% | 642,348 | +0.8% | 1.01% | -4.2% |
Q1 2014 | $34,032,000 | -7.3% | 636,940 | -7.3% | 1.05% | +2.0% |
Q4 2013 | $36,696,000 | +8.3% | 687,316 | +1.8% | 1.03% | -16.4% |
Q3 2013 | $33,881,000 | +1.1% | 675,329 | +0.7% | 1.23% | +11.7% |
Q2 2013 | $33,516,000 | – | 670,707 | – | 1.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |